These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 30472020)

  • 1. KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.
    Hinohara K; Wu HJ; Vigneau S; McDonald TO; Igarashi KJ; Yamamoto KN; Madsen T; Fassl A; Egri SB; Papanastasiou M; Ding L; Peluffo G; Cohen O; Kales SC; Lal-Nag M; Rai G; Maloney DJ; Jadhav A; Simeonov A; Wagle N; Brown M; Meissner A; Sicinski P; Jaffe JD; Jeselsohn R; Gimelbrant AA; Michor F; Polyak K
    Cancer Cell; 2018 Dec; 34(6):939-953.e9. PubMed ID: 30472020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
    Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
    J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM5 lysine demethylases are involved in maintenance of 3'UTR length.
    Blair LP; Liu Z; Labitigan RL; Wu L; Zheng D; Xia Z; Pearson EL; Nazeer FI; Cao J; Lang SM; Rines RJ; Mackintosh SG; Moore CL; Li W; Tian B; Tackett AJ; Yan Q
    Sci Adv; 2016 Nov; 2(11):e1501662. PubMed ID: 28138513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis.
    Yoo J; Kim GW; Jeon YH; Kim JY; Lee SW; Kwon SH
    Exp Mol Med; 2022 Dec; 54(12):2107-2117. PubMed ID: 36509829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance.
    Gaillard S; Charasson V; Ribeyre C; Salifou K; Pillaire MJ; Hoffmann JS; Constantinou A; Trouche D; Vandromme M
    Biol Open; 2021 May; 10(5):. PubMed ID: 34184733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design and discovery of potent and selective KDM5 inhibitors.
    Nie Z; Shi L; Lai C; O'Connell SM; Xu J; Stansfield RK; Hosfield DJ; Veal JM; Stafford JA
    Bioorg Med Chem Lett; 2018 May; 28(9):1490-1494. PubMed ID: 29627262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting histone demethylases KDM5A and KDM5B in AML cancer cells: A comparative view.
    Shokri G; Doudi S; Fathi-Roudsari M; Kouhkan F; Sanati MH
    Leuk Res; 2018 May; 68():105-111. PubMed ID: 29602065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Molecule Inhibitors of KDM5 Histone Demethylases Increase the Radiosensitivity of Breast Cancer Cells Overexpressing JARID1B.
    Pippa S; Mannironi C; Licursi V; Bombardi L; Colotti G; Cundari E; Mollica A; Coluccia A; Naccarato V; La Regina G; Silvestri R; Negri R
    Molecules; 2019 May; 24(9):. PubMed ID: 31060229
    [No Abstract]   [Full Text] [Related]  

  • 9. The KDM5 family of histone demethylases as targets in oncology drug discovery.
    Rasmussen PB; Staller P
    Epigenomics; 2014 Jun; 6(3):277-86. PubMed ID: 25111482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs regulate KDM5 histone demethylases in breast cancer cells.
    Denis H; Van Grembergen O; Delatte B; Dedeurwaerder S; Putmans P; Calonne E; Rothé F; Sotiriou C; Fuks F; Deplus R
    Mol Biosyst; 2016 Feb; 12(2):404-13. PubMed ID: 26621457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.
    Klein BJ; Piao L; Xi Y; Rincon-Arano H; Rothbart SB; Peng D; Wen H; Larson C; Zhang X; Zheng X; Cortazar MA; Peña PV; Mangan A; Bentley DL; Strahl BD; Groudine M; Li W; Shi X; Kutateladze TG
    Cell Rep; 2014 Jan; 6(2):325-35. PubMed ID: 24412361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.
    Xue S; Lam YM; He Z; Zheng Y; Li L; Zhang Y; Li C; Mbadhi MN; Zheng L; Cheng Z; Liu Y; Wang X; Chan LC; Ng RK; Zhang J
    Exp Hematol; 2020 Feb; 82():53-65. PubMed ID: 32007477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
    Li CY; Wang W; Leung CH; Yang GJ; Chen J
    Mol Cancer; 2024 May; 23(1):109. PubMed ID: 38769556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases.
    Paroni G; Bolis M; Zanetti A; Ubezio P; Helin K; Staller P; Gerlach LO; Fratelli M; Neve RM; Terao M; Garattini E
    Oncogene; 2019 Apr; 38(15):2675-2689. PubMed ID: 30538297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer.
    Shen WJ; Kao HM; Wang CY; Kousar R; Lin JS; Ko CC; Lin HY; Ta HDK; Anuraga G; Xuan DTM; Kumar S; Dey S; Ly NP; Wang WJ
    Int J Med Sci; 2024; 21(11):2158-2169. PubMed ID: 39239542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen therapy induces an unfolded protein response to drive cell death in ER+ breast cancer.
    Hosford SR; Shee K; Wells JD; Traphagen NA; Fields JL; Hampsch RA; Kettenbach AN; Demidenko E; Miller TW
    Mol Oncol; 2019 Aug; 13(8):1778-1794. PubMed ID: 31180176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and clinical significance of KDM5A, KDM5B, and FOXO1 in endometrial cancer.
    Gao Y; Gao J
    Pol J Pathol; 2024; 75(2):83-96. PubMed ID: 39166517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance.
    Gale M; Sayegh J; Cao J; Norcia M; Gareiss P; Hoyer D; Merkel JS; Yan Q
    Oncotarget; 2016 Jun; 7(26):39931-39944. PubMed ID: 27224921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the Arabidopsis JMJ14-H3K4me3 Complex Provides Insight into the Substrate Specificity of KDM5 Subfamily Histone Demethylases.
    Yang Z; Qiu Q; Chen W; Jia B; Chen X; Hu H; He K; Deng X; Li S; Tao WA; Cao X; Du J
    Plant Cell; 2018 Jan; 30(1):167-177. PubMed ID: 29233856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.